AYTU BIOPHARMA INC (AYTU) Stock Income Statement
NASDAQ:AYTU • US0547548588
Current stock price
2.54 USD
-0.1 (-3.79%)
Last:
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 62.64M | 66.38M | 65.18M | 107.40M | 96.70M | |||
| Cost Of Goods | 20.77M | 20.55M | 16.13M | 40.80M | 44.40M | |||
| Gross Profit | 41.87M | 45.83M | 49.05M | 66.60M | 52.30M | |||
| Operating Expenses | 42.28M | 43.29M | 48.49M | 78.00M | 86.70M | |||
| Research and Development | 378.00K | 1.33M | 2.77M | 4.10M | 12.70M | |||
| Selling, General, and Administrative Expenses | 39.09M | 38.28M | 42.04M | 70.10M | 69.90M | |||
| Operating Income | -413.00K | 2.54M | 565.00K | -11.40M | -34.40M | |||
| Interest Income/Expense | -15.57M | -5.92M | -8.19M | 0.00 | -800.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 4.79M | 1.60M | |||
| Non Recurring Items | -8.26M | -10.36M | -2.75M | -5.70M | -75.30M | |||
| Income Before Taxes | -24.24M | -13.74M | -10.38M | -17.10M | -108.90M | |||
| Income Tax | 315.00K | 437.00K | 2.14M | 0.00 | -100.00K | |||
| Net Income | -24.44M | -13.56M | -15.84M | -17.10M | -108.80M | |||
| EBITDA | 3.89M | 7.91M | 8.84M | -2.58M | -24.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.40 | -2.15 | -2.86 | -5.18 | -72.53 | |||
| Non GAAP EPS | -3.55 | -2.53 | -2.86 | -5.03 | -76.20 | |||
| Statistics | ||||||||
| Gross Profit Margin | 66.84% | 69.04% | 75.26% | 62.01% | 54.08% | |||
| Profit Margin | -39.02% | -20.43% | -24.31% | -15.92% | -112.51% | |||
| Operating Profit Margin | -0.66% | 3.82% | 0.87% | -10.61% | -35.57% | |||
All data in USD